Reduced chromogranin a cell density in the ileum of patients with irritable bowel syndrome

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1241-1244

  El Salhy, Magdy ^a,b   Wendelbo, Ingvild Haukaas ^a,b   Gundersen, Doris ^c  

^a Stord Helse Fonna Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Helse Fonna ^*  (Norway)

Author keywords

Chromogranin A; Computer image analysis; Ileum; Immunohistochemistry; Irritable bowel syndrome

Indexed keywords

AVIDIN; BIOLOGICAL MARKER; BIOTIN; CHROMOGRANIN A;

ADULT; AGED; ARTICLE; CELL DENSITY; COLON BIOPSY; COLONOSCOPY; COMPUTER ANALYSIS; CONSTIPATION; DIARRHEA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUM DISEASE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MAJOR CLINICAL STUDY; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CELL COUNT; CHROMOGRANIN A; COLONOSCOPY; ENDOCRINE CELLS; HUMANS; ILEUM; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED;

EID: 84875265864     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1325     Document Type: Article

References (31)

1. El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T (eds): Irritable Bowel Syndrome: Diagnosis, Pathogenesis & Treatment Options. Nova Science Publishers Inc., New York, NY, 2012.
2. Thompson WG: A world view of IBS. In: Irritable Bowel Syndrome: Diagnosis and Treatment. Camilleri M and Spiller R (eds). Saunders, Philadelphia and London, pp17-26, 2002.
3. Drossman DA, Li Z, Andruzzi E, et al: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38: 1569-1580, 1993.
4. Hungin AP, Whorwell PJ, Tack J and Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 17: 643-650, 2003.
5. Wilson S, Roberts L, Roalfe A, Bridge P and Singh S: Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 54: 495-502, 2004.
6. Whitehead WE, Burnett CK, Cook EW III and Taub E: Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 41: 2248-2253, 1996.
7. Everhart JE and Renault PF: Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 100: 998-1005, 1991.
8. Harvey RF, Salih SY and Read AE: Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1: 632-634, 1983.
9. Taupenot L, Harper KL and O'Connor DT: The chromogranin-secretogranin family. N Engl J Med 348: 1134-1149, 2003.
10. Wiedenmann B and Huttner WB: Synaptophysin and chromogranins/ secretogranins - widespread constituents of distinct types of neuroendocrine vesicales and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol 58: 95-121, 1989.
11. El-Salhy M, Lillebø E, Reinemo A and Salmelid L: Ghrelin in patients with irritable bowel syndrome. Int J Mol Med 23: 703-707, 2009.
12. Sjölund K, Ekman R and Wierup N: Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Peptides 31: 1109-1112, 2010.
13. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M and Hausken T: Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 31: 883-891, 2010.
14. El-Salhy M, Vaali K, Dizdar V and Hausken T: Abnormal small intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci 55: 3508-3513, 2010.
15. El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci 57: 873-878, 2012.
16. El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Submitted, 2012.
17. El-Salhy M, Seim I, Chopin L, Gundersen D, Hatlebakk JG and Hausken T: Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed) 4: 2783-2800, 2012.
18. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM and Moses PL: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664, 2004.
19. Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL and Han SP: Decreased expression of serotonin in the jejenum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol 13: 6041-6047, 2007.
20. Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC and Song SY: Enteroendocrine cell counts correlated with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil 18: 539-546, 2006.
21. Dunlop SP, Jenkins D and Spiller RC: Distinctive clinical, psychological and histological feature of postinfective irritable bowel syndrome. Am J Gastroenterol 98: 1578-1583, 2003.
22. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK and Cho SW: The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 23: 1689-1694, 2008.
23. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47: 804-811, 2000.
24. Kim HS, Lim JH, Park H and Lee SI: Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection - an observation in small case control study. Yonsei Med J 51: 45-51, 2010.
25. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA and Spiller RC: Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3: 349-357, 2005.
26. Deftos LJ: Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 12: 181-187, 1991.
27. El-Salhy M, Lomholt-Beck B and Hausken T: Chromogranin as a tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol 45: 1435-1439, 2010.
28. El-Salhy M, Mazzawi T, Gundersen D and Hausken T: Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep 6: 1223-1225, 2012.
29. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F and Spiller RC: Functional bowel disorder. Gastroenterology 130: 1480-1491, 2006.
30. Sandström O and El-Salhy M: Aging and endocrine cells of human duodenum. Mech Ageing Dev 108: 39-48, 1999.
31. Sandström O and El-Salhy M: Human rectal endocrine cells and aging. Mech Ageing Dev 108: 219-226, 1999.